Clene (NASDAQ: CLNN) director granted 3,564 stock options at $6.81 exercise price
Rhea-AI Filing Summary
Clene Inc. director Vallerie McLaughlin received stock option awards as equity compensation. On May 21, 2026, she was granted options covering a total of 3,564 shares of common stock at an exercise price of $6.81 per share under the Clene Inc. Amended 2020 Stock Plan.
One option grant for 2,064 shares vests immediately, giving her the right to purchase those shares at the set price. A second option grant for 1,500 shares vests in 12 equal monthly installments on the 21st of each month starting June 21, 2026, extending through the following year. Both option series expire on May 20, 2036 if not exercised.
Positive
- None.
Negative
- None.
Insights
Routine director stock option grants with staged vesting and long-term expiry.
Clene Inc. granted director Vallerie McLaughlin stock options over 3,564 shares of common stock at an exercise price of $6.81 per share. These awards are classified as grants, not open-market purchases or sales, and represent standard equity-based compensation.
One 2,064-share grant vests immediately, while a 1,500-share grant vests monthly over 12 months starting June 21, 2026, with both expiring on May 20, 2036. The filing shows no option exercises or share sales, and derivative positions beyond these awards are not listed. Overall, the transactions appear routine and do not by themselves signal a change in outlook.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | stock option | 1,500 | $0.00 | -- |
| Grant/Award | stock option | 2,064 | $0.00 | -- |
Footnotes (1)
- This option was granted on May 21, 2026 as an option for 1,500 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest in 12 equal monthly installments on the 21st day of each calendar month, beginning June 21, 2026, until such shares are fully vested. This option was granted on May 21, 2026 as an option for 2,064 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest immediately upon grant.